SYS6002 vs PADCEV in Patients With Advanced Urothelial Carcinoma
Clinical trial NCT07374549 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07374549
- Sponsor
- CSPC Megalith Biopharmaceutical Co.,Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-20
- Primary completion
- 2028-06-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.